March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Learn about the 4 essential types of diabetes, their unique characteristics, risk factors, and management strategies to ...

Previous research has found that immigrants have lower rates of heart disease, diabetes, dementia and other chronic health ...

Type 2 diabetes is a serious health condition that is becoming more common in both kids and adults. In the past, it mostly ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...